Company / Free Cash Flow
TENAX THERAPEUTICS, INC. Free Cash Flow History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$9.3M
FY2016
5-year range
-$9.3M / -$4.9M
FY2012-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$5M to -$9M over the past 2 years.
Based on SEC 10-K filings.
-$9M in FY2016.
Declined from -$5M to -$9M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, free cash flow increased 0.0% year-over-year.
- Peak free cash flow was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2016 | -$9.3M | +0.0% |
| FY2015 | -$9.3M | -87.7% |
| FY2014 | -$4.9M | +40.5% |
| FY2013 | -$8.3M | +4.0% |
| FY2012 | -$8.6M | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026